Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,392,610
-
Total 13F shares
-
24,614,198
-
Share change
-
+24,614,198
-
Total reported value
-
$385,430,964
-
Price per share
-
$15.66
-
Number of holders
-
66
-
Value change
-
+$385,430,964
-
Number of buys
-
66
Institutional Holders of Mineralys Therapeutics, Inc. - Common Stock (MLYS) as of Q1 2023
As of 31 Mar 2023 Mineralys Therapeutics, Inc. - Common Stock (MLYS) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,614,198 shares of stock of the company.
Largest 10 holders included Samsara BioCapital, LLC, RA CAPITAL MANAGEMENT, L.P., ADAMS STREET PARTNERS LLC, SR ONE CAPITAL MANAGEMENT, LP, Avidity Partners Management LP, Rock Springs Capital Management LP, RTW INVESTMENTS, LP, BlackRock Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Laurion Capital Management LP.
This table shows 66 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.